OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 419

Showing 1-25 of 419 citing articles:

Neutralizing Antibody Therapeutics for COVID-19
Aeron C. Hurt, Adam K. Wheatley
Viruses (2021) Vol. 13, Iss. 4, pp. 628-628
Open Access | Times Cited: 118

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 104

Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
Mohsen Ahmadi, Sander Bekeschus, Klaus‐Dieter Weltmann, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 5, pp. 471-496
Open Access | Times Cited: 104

Nucleoside‐Based Drug Target with General Antimicrobial Screening and Specific Computational Studies against SARS‐CoV‐2 Main Protease
Sarkar M. A. Kawsar, Md. Ahad Hossain, Supriyo Saha, et al.
ChemistrySelect (2024) Vol. 9, Iss. 15
Closed Access | Times Cited: 23

Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 74

Face Mask Use in the Community for Reducing the Spread of COVID-19: A Systematic Review
Daniela Coclite, Antonello Napoletano, Silvia Gianola, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 70

A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
Ankit Gupta, Anjali Anand, Neha Jain, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 321-332
Open Access | Times Cited: 67

The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 63

Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review
Tianbao Li, Tao Huang, Cheng Guo, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100116-100116
Open Access | Times Cited: 56

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55

The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection
Patty Karina dos Santos, Emilly Sigoli, Lorenna J.G. Bragança, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 48

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38

Use of a risk assessment tool to determine the origin of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Xin Chen, Fatema Kalyar, Abrar Ahmad Chughtai, et al.
Risk Analysis (2024) Vol. 44, Iss. 8, pp. 1896-1906
Open Access | Times Cited: 12

Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7

Vitamin D and COVID-19: An Overview of Recent Evidence
Drishti P. Ghelani, Simon Alesi, Aya Mousa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10559-10559
Open Access | Times Cited: 54

Principles and Challenges in anti-COVID-19 Vaccine Development
Zuzana Střížová, Jitka Smetanová, Jiřina Bartůňková, et al.
International Archives of Allergy and Immunology (2021) Vol. 182, Iss. 4, pp. 339-349
Open Access | Times Cited: 53

A comprehensive review on current COVID-19 detection methods: From lab care to point of care diagnosis
Bishal Singh, Brateen Datta, Amlan Ashish, et al.
Sensors International (2021) Vol. 2, pp. 100119-100119
Open Access | Times Cited: 51

Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types
Abhishek Gupta, Rajesh Karyakarte, Suvarna Joshi, et al.
Microbes and Infection (2021) Vol. 24, Iss. 1, pp. 104880-104880
Open Access | Times Cited: 51

Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 5, pp. 1815-1820
Closed Access | Times Cited: 48

Rapid characterization of spike variants via mammalian cell surface display
Kamyab Javanmardi, Chia‐Wei Chou, Cynthia I. Terrace, et al.
Molecular Cell (2021) Vol. 81, Iss. 24, pp. 5099-5111.e8
Open Access | Times Cited: 45

A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19
Neha Srivastava, Prekshi Garg, Prachi Srivastava, et al.
PeerJ (2021) Vol. 9, pp. e11171-e11171
Open Access | Times Cited: 44

Page 1 - Next Page

Scroll to top